We are live on
!
Find out more
B
Bailard Portfolio holdings
AUM
$4.35B
1-Year Est. Return
23.57%
This Fund
S&P 500
This Quarter
Est. Return
+4.29%
1 Year Est. Return
+23.57%
3 Year Est. Return
+74.84%
5 Year Est. Return
+96.64%
10 Year Est. Return
+374.16%
AUM
$1.64B
AUM Growth
+$23.5M
(+1.5%)
Cap. Flow
-$31.1M
Cap. Flow
% of AUM
-1.9%
Top 10 Holdings %
Top 10 Hldgs %
31.5%
Holding
630
New
91
Increased
163
Reduced
168
Closed
91
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$56.7M |
| 2 |
Vanguard Total Bond Market
BND
|
+$56M |
| 3 |
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
|
+$16.8M |
| 4 |
iShares US Treasury Bond ETF
GOVT
|
+$11.4M |
| 5 |
iShares MBS ETF
MBB
|
+$11.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$58.5M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$31.9M |
| 3 |
iShares Gold Trust
IAU
|
+$29.4M |
| 4 |
SPDR Gold Trust
GLD
|
+$22.9M |
| 5 |
State Street SPDR Nuveen ICE Municipal Bond ETF
TFI
|
+$8.19M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.03% |
| 2 | Healthcare | 7.09% |
| 3 | Financials | 4.96% |
| 4 | Communication Services | 4.91% |
| 5 | Industrials | 4.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Adeia
ADEA
$2.97B
| $425K | 0.03% |
78,057
+7,938
| +11% | +$47.7K |
|
327
Hilltop Holdings
HTH
$2.22B
| $423K | 0.03% |
+19,900
| New | +$401K |
|
|
PRSP
328
DELISTED
Perspecta Inc. Common Stock
PRSP
| $423K | 0.03% |
+18,074
| New | +$406K |
|
|
SYKE
329
DELISTED
SYKES Enterprises Inc
SYKE
| $417K | 0.03% |
15,200
| – | – |
|
|
ARI
330
Apollo Commercial Real Estate
ARI
$885M
| $416K | 0.03% |
22,640
| – | – |
|
331
Neurocrine Biosciences
NBIX
$17.5B
| $414K | 0.03% |
4,900
| – | – |
|
|
SEM
332
DELISTED
Select Medical
SEM
| $413K | 0.03% |
+48,297
| New | +$382K |
|
333
International Bancshares
IBOC
$4.71B
| $411K | 0.03% |
+10,900
| New | +$428K |
|
334
Oshkosh
OSK
$9.47B
| $410K | 0.03% |
4,915
+400
| +9% | +$31.5K |
|
335
Matthews International
MATW
$844M
| $406K | 0.02% |
11,650
+800
| +7% | +$29.3K |
|
336
Tredegar Corp
TG
$270M
| $406K | 0.02% |
24,400
-9,200
| -27% | -$156K |
|
337
Mativ Holdings
MATV
$433M
| $405K | 0.02% |
12,200
| – | – |
|
338
Vertex Pharmaceuticals
VRTX
$120B
| $403K | 0.02% |
2,200
| – | – |
|
339
Unilever
UL
$130B
| $401K | 0.02% |
5,747
+2,143
| +59% | +$145K |
|
340
Vanguard Financials ETF
VFH
$13.2B
| $401K | 0.02% |
5,805
| – | – |
|
341
OneMain Financial
OMF
$6.79B
| $399K | 0.02% |
11,800
+1,000
| +9% | +$32.6K |
|
|
CISN
342
DELISTED
Cision Ltd. Ordinary Share
CISN
| $399K | 0.02% |
+34,000
| New | +$403K |
|
343
Rio Tinto
RIO
$149B
| $398K | 0.02% |
6,392
+1,083
| +20% | +$64.9K |
|
344
Ross Stores
ROST
$74.6B
| $397K | 0.02% |
4,005
+195
| +5% | +$19K |
|
345
Arcosa
ACA
$7.12B
| $395K | 0.02% |
10,500
+1,900
| +22% | +$65K |
|
346
Builders FirstSource
BLDR
$7.59B
| $395K | 0.02% |
+23,400
| New | +$350K |
|
347
Pediatrix Medical
MD
$2.1B
| $395K | 0.02% |
+15,650
| New | +$420K |
|
348
Taylor Morrison
TMHC
$6.67B
| $394K | 0.02% |
+18,800
| New | +$374K |
|
349
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14B
| $391K | 0.02% |
6,733
-780
| -10% | -$44.7K |
|
350
Blackstone
BX
$152B
| $388K | 0.02% |
8,737
+747
| +9% | +$29.8K |
|
Similar funds
EC
SFM
NHC
EQF
NEI
MYIA
Bailard's Q2 2019 Portfolio in Review
As of Q2 2019, Bailard held 630 positions worth $1.64B, up 1.5% from $1.61B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Bailard's Q2 2019 filing shows 91 new, 163 increased, 168 reduced and 91 closed positions. Its largest new stake was Vanguard Total Bond Market: 687,016 shares worth $57.1M. The largest sale was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund, an estimated $58.5M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Financials.
- Bailard's largest Q2 2019 buy was Vanguard Total Bond Market: 687,016 shares worth $57.1M.
- Bailard added most to iShares US Real Estate ETF in Q2 2019, an estimated $56.7M increase.
- Bailard's biggest Q2 2019 reduction was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund, cutting an estimated $58.5M.
- Bailard fully exited Teva Pharmaceuticals in Q2 2019, selling an estimated $5.65M.
- Bailard's ten largest holdings make up 32% of its $1.64B portfolio in Q2 2019.
- Bailard opened 91 new positions and closed 91 in Q2 2019.
- Bailard's portfolio value rose 1.5% quarter-over-quarter to $1.64B.
Based on Bailard's 13F filing for Q2 2019, filed 26 Jul 2019.